Triple

T3803133
Position Surface form Disambiguated ID Type / Status
Subject Stuart L. Schreiber E91736 entity
Predicate coFounderOf P104 FINISHED
Object H3 Biomedicine
H3 Biomedicine is a biotechnology company focused on discovering and developing precision cancer therapies using genomics-driven approaches.
E387619 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: H3 Biomedicine | Statement: [Stuart L. Schreiber, coFounderOf, H3 Biomedicine]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: H3 Biomedicine
Context triple: [Stuart L. Schreiber, coFounderOf, H3 Biomedicine]
  • A. Insitro
    Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
  • B. Samsung Biologics
    Samsung Biologics is a South Korean biopharmaceutical company specializing in contract development and manufacturing (CDMO) of biologic drugs for global pharmaceutical and biotech firms.
  • C. Verily Life Sciences LLC
    Verily Life Sciences LLC is a health-focused research and technology company that develops tools and platforms to collect, organize, and analyze health data, particularly in areas like clinical research, precision health, and disease management.
  • D. ICMBio
    ICMBio is Brazil’s federal agency responsible for managing and protecting the country’s conservation units and biodiversity.
  • E. BioNTech
    BioNTech is a German biotechnology company best known for developing one of the first mRNA-based COVID-19 vaccines in partnership with Pfizer.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: H3 Biomedicine
Triple: [Stuart L. Schreiber, coFounderOf, H3 Biomedicine]
Generated description
H3 Biomedicine is a biotechnology company focused on discovering and developing precision cancer therapies using genomics-driven approaches.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: H3 Biomedicine
Target entity description: H3 Biomedicine is a biotechnology company focused on discovering and developing precision cancer therapies using genomics-driven approaches.
  • A. Insitro
    Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
  • B. Samsung Biologics
    Samsung Biologics is a South Korean biopharmaceutical company specializing in contract development and manufacturing (CDMO) of biologic drugs for global pharmaceutical and biotech firms.
  • C. Verily Life Sciences LLC
    Verily Life Sciences LLC is a health-focused research and technology company that develops tools and platforms to collect, organize, and analyze health data, particularly in areas like clinical research, precision health, and disease management.
  • D. ICMBio
    ICMBio is Brazil’s federal agency responsible for managing and protecting the country’s conservation units and biodiversity.
  • E. BioNTech
    BioNTech is a German biotechnology company best known for developing one of the first mRNA-based COVID-19 vaccines in partnership with Pfizer.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69aed96354f48190a768966d6bd19b04 completed March 9, 2026, 2:29 p.m.
NER Named-entity recognition batch_69aee7bacf2881908198a77063d15d16 completed March 9, 2026, 3:31 p.m.
NED1 Entity disambiguation (via context triple) batch_69b4f06889c88190ab4d8da7f0dfeadd completed March 14, 2026, 5:21 a.m.
NEDg Description generation batch_69b4f0e77efc8190b4459d4559261a2f completed March 14, 2026, 5:23 a.m.
NED2 Entity disambiguation (via description) batch_69b4f15cfde88190bcb2680b90f98111 completed March 14, 2026, 5:25 a.m.
Created at: March 9, 2026, 3:15 p.m.